In a question-and-answer session on Saturday (03.12.22), he made the remarks while talking about possible reprisals for his so-called “Twitter Files” leaks.
A day after journalist Matt Taibbi released information concerning restrictions on the social media platform, Kim Dotcom questioned Elon, 51, about his personal safety and inquired whether he was experiencing any “suιcιdal thoughts.”
I do not have any suιcιdal thoughts, Elon retorted. If I killed myself, it wasn’t really me.
The Tesla bιllιonaire added that because of his high-profile actions at Twitter, which he successfully acquired for $44 bιllιon on October 28, he thought he faced a heightened rιsk to his personal safety, including attempts on his life.
The possibility of something horrible happening or maybe literally getting shot, he admitted, is quite high.
“Let me be clear: I will not be participating in any open-air car parades. If someone wanted to kill me, it wouldn’t be that difficult, so hopefully they won’t.
“Perhaps I should be more concerned than I am, but I believe that generally speaking, if you treat people correctly, they will support you.”
After arguing with a Russian official online in May, dad-of-10 Elon tweeted cryptically: “If I Ԁιe under strange circumstances, it’s been good knowin ya.”
Elon Musk’s ‘miracle’ Brain Chip: Help the Blind See and the PаrаlyzeԀ Walk
Recently, billionaire Elon Musk said that his technology company Neuralink developed will test implanting chips into the human brain in six months, after the company missed previously set timelines.
The company is developing brain chip interfaces that will allow disabled patients to move and communicate again, while working towards the goal of restoring vision, Elon Musk said on Nov. 30.
The principle of operation of the Neuralink chip is to implant electrodes in the area of the brain that controls voluntary movement, and then connect to a network in charge of processing, arousing and transmitting nerve signals.
Previously, Neuralink, based in the San Francisco Bay Area and Austin, Texas, successfully implanted chips in the brains of pigs and monkeys and recorded positive results. Specifically, the Neuralink chip helped the monkey to play games with his mind.
Neuralink chip helps monkeys can play games with their thoughts
Elon Musk said he will perform the first transplant into the brain of people, who have severe spinal cord injuries or quadriplegia, after being approved by the US Food and Drug Administration (FDA). .
“We want to be very careful and make sure the chip will work properly before we put it into people,” Musk said at the device public event.
Speaking to representatives at Neuralink headquarters lasting nearly three hours, Mr. Musk emphasized the pace of development of his device: “Initial progress, especially when implanting in humans, is likely to be very slow, But we’re working hard to stay on track.”
Elon Musk said the first two human uses for the Neuralink device are to restore vision and mobility in people with disabilities. “Even if someone has never had vision, for example they were born blind, we believe we can still restore vision,” he said.
It is known that the event was originally scheduled for October 31, but Elon Musk postponed the previous date without giving a reason.
Elon Musk, who runs electric vehicle maker Tesla, rocket company SpaceX and social media platform Twitter, is known for lofty goals like making Mars a “colony” of Earth. His ambitions for Neuralink, first announced in 2016, are similarly grand.
He wants to develop a chip that will allow the brain to control complex electronic devices and eventually allow paralyzed people to regain motor function as well as treat brain diseases such as Parkinson’s, dementia, and dementia. Alzheimer. He also gives information about combining the brain with artificial intelligence.
However, Neuralink is still behind the original plan. Musk said in 2019 he is aiming to get regulatory approval by the end of 2020. Then, speaking at a conference in late 2021 he hopes to begin human trials this year. .
However, the company completed studies of four people in Australia in 2021 and implanted its device in a patient in the US for the first time in July, Reuters reported.
